Диссертация (1174270), страница 33
Текст из файла (страница 33)
– P. 2068-72.49.Antonini, A. ICARUS study: prevalence and clinical features of impulse controldisorders in Parkinson’s disease / A. Antonini, P. Barone, U. Bonuccelli, K.192Annoni, M. Asgharnejad, P. Stanzione // J Neurol Neurosurg Psychiatry. - 2017.– V. 88. - №4. – P. 317–324.50.Bachman, J.G. Racial/Ethnic differences in smoking, drinking, and illicit druguse among American high school seniors, 1976-89 / J.G. Bachman, J.M.Wallace, P.M.
O'Malley, L.D. Johnston, C.L. Kurth, H.W. Neighbors // J PublicHealth. – 1991. – V. 81. - №3. – P. 372–377.51. Baj, G. Toward a unified biological hypothesis for the BDNF Val66Metassociated memory deficits in humans: a model of impaired dendritic mRNAtrafficking / G. Baj, D. Carlino, L. Gardossi, E.
Tongiorgi // Front Neurosci. –2013. – V.7. – P. 188.52.Barratt, E.S. Impulsivity: Integrating cognitive, behavioral, biological andenvironmental data // The Impulsive client: theory, research, and treatment / eds.W.G. McCown, J. Johnson , M.B. Shure, D.C. Washington: AmericanPsychological Association, 1993.
- P. 3956.53.Barratt, E.S. Neuropsychological and cognitive psychophysiological substratesof impulsive aggression/ E.S. Barratt, M.S. Stanford, T.A. Kent, A. Felthous //Biological psychiatry. - 1997. - V.41. - № 10. - Р. 1045–61.54.Bastiaens, J. Prospective cohort study of impulse control disorders in Parkinson'sdisease / J. Bastiaens, B.J. Dorfman, P.J. Christos, M.J. Nirenberg // Mov Disord.– 2013. V. 28. - №3. – P. 327–33.55.Baumann, C.
Parkinsonism with excessive daytime sleepiness – a narcolepsylike disorder? / C. Baumann, L. Ferini-Strambi, D. Waldvogel // J. Neurol. –2005. – V. 252. - №2. – P. 139-145.56.Baumann-Vogel, H. Impulse control disorders in Parkinson’s disease: don’t setyour mind at rest by self-assessments / H. Baumann-Vogel, P.O. Valko,G.Eisele, C.R.Baumann // European Journal of Neurology. – 2015. – V. 22. №4. – P.
603–609.57.Bayard, S. Impulse control disorder and rapid eye movement sleep behaviordisorder in Parkinson’s disease / S. Bayard, Y. Dauvilliers, H. Yu, M. Croisier-193Langenier, A. Rossignol, M. Charif, C. Geny, B. Carlander, D. C. Cochen //Parkinsonism and Related Disorders. – 2014. – V.20. - №12. – P. 1411–1414.58.Berridge, K.C. The debate over dopamine’s role in reward: The case forincentive salience / K.C. Berridge // Psychopharmacology (Berl).
– 2007. – V.191. - №3. – P. 391-431.59.Bienfait, K.L. Impulsive smoking in a patient with Parkinson’s disease treatedwith dopamine agonists / K. L. Bienfait, M. Menza, M.H. Mark, R.D. Dobkin //Journal of Clinical Neuroscience. – 2010. – V. 17. - №4. – P. 539–540.60.Black, D.W. A review of compulsive buying disorder / D.W. Black // WorldPsychiatry. – 2007. – V. 6. - №1.
– P. 14–18.61.Boeve, B.F. REM sleep behavior disorder: Updated review of the core features,the REM sleep behavior disorder-neurodegenerative disease association,evolving concepts, controversies, and future directions / B.F. Boeve // Ann N YAcad Sci. – 2010. – V. 1184.
– P. 15—54.62.Bonnet, A.M. Nonmotor symptoms in Parkinson’s disease in 2012: Relevantclinical aspects / A.M. Bonnet, M.F. Jutras, V. Czernecki, J.C. Corvol, M.Vidailhet // Parkinson’s Dis. – 2012.63.Bonvin, C. Compulsive singing:another aspect of punding in Parkinson’s disease/ C. Bonvin, J. Horvath, B. Christe, T. Landis, P.R. Burkhard // Ann. Neurol. –2007. – V. 62. - №5. – P. 525–528.64.Brady, K.T.
Cocaine-induced psychosis / K.T. Brady, R.B. Lydiard, R. Malcolm,J.C., J.C. Ballenger // J Clin Psychiatry. –1991. – V.52. - №12. – P. 509-12.65.Bhattacharjee, S. Impulse control disorders in Parkinson's disease: Review ofpathophysiology, epidemiology, clinical features, management, and futurechallenges / S.Brattacharjee // Neurol India. – 2018. – V.66. - №4. – P. 967-975.66.Cabrini, S.
Preliminary evaluation of the DDS-PC inventory: a new tool to assessimpulsive-compulsive behaviours associated to dopamine replacement therapy inParkinson's disease / S. Cabrini, M. Baratti, F. Bonfà, G. Cabri, E. Uber, M.Avanzi // Neurological Sciences. - 2009. - V. 30. - №4.
- P. 307–313.19467.Callesen, M.B. A systematic review of Impulse Control Disorders inParkinson’s disease / M.B. Callesen, J. Scheel-Krüger, M.L. Kringelbach, A.J.Møller // Parkinsons Dis. – 2013. – V.3. - №2. – P. 105-38.68.Callesen, M. Impulsive and compulsive behaviors among Danish patients withParkinson’s disease: prevalence, depression, and personality / M.B. CallesenMB, D. Weintraub, M.F. Damholdt, A. Møller // Parkinsonism Relat Disord. –2014. – V. 20. - №1.
– P. 22-26.69.Carbunaru, S. Impulse control disorders in Parkinson’s: sleep disorders andnondopaminergic associations / S. Carbunaru, R.S. Eisinger, A. RamirezZamora, D. Bassan, A. Cervantes-Arriaga, M. Rodriguez-Violante, D. MartinezRamirez //Brain Behav. – 2018. – V. 8. - №3.
- e0090470.Cetin F.H. Carboxylesterase1, alpha 2a adrenergic receptor and noradrenalintransporter gene polymorphisms and their clinical effects in attention deficithyperactivity disorder in Turkish children / F.H. Cetin , Y. Isık, Y. T. Torun, E.Alp, A. Yılmaz, I. H. Onen // Gene Reports. – 2018. – V.11. – P. 58-68.71.
Chen, Z.Y. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters theintracellular trafficking and activity-dependent secretion of wild-type BDNF inneurosecretory cells and cortical neurons / Z.Y. Chen, P.D. Patel, G. Sant, C.X.Meng, K.K. Teng, B.L. Hempstead, F.S. Lee // J Neurosci. – 2004. – V.24. №18. – P. 4401-4411.72.Chiang, H.L.
Are there ethnic differences in impulsive/compulsive behaviors inParkinson's disease? / H.L. Chiang, Y.S. Huang, S.T. Chen, Y.R. Wu // Eur JNeurol. – 2012. – V. 19. - №3. – P. 494–500.73.Christenson, G. Compulsive buying: descriptive characteristics and psychiatriccomorbidity / G.A. Christenson, R.J. Faber, M. de Zwaan, N.C. Raymond, S.M.Specker, M.D. Ekern, T.B. Mackenzie, R.D.
Crosby, S.J. Crow, E.D. Eckert //Journal of Clinical Psychiatry. - 1994. - V. 55. - №1. - P. 5–11.74.Chung, S.K. Changes of functional MRI findings in a patient whose pathologicalgambling improved with fluvoxamine / S.K. Chung, I.H. You, G.H. Cho, G.H.195Chung, Y.C. Shin, D.J. Kim, S.W. Choi // Yonsei Med J. – 2009. – V. 50. - №3.– P. 441-444.75.Cilia, R. Reduced dopamine transporter density in the ventral striatum of patientswith Parkinson’s disease and pathological gambling / R. Cilia, J.H.
Ko, S.S. Cho,T. van Eimeren, G. Marotta, G. Pellecchia, G. Pezzoli, A. Antonini, A.P.Strafella // Neurobiol Dis. – 2010. – V.39. - №1. – P. 98–104.76.Comella, C. Sleep disorders in Parkinson’s disease: an overview / C. Comella //Mov. Disord. – 2007. – V. 22, - №17. – P. 367–373.77.Comings, D.E. The dopamine D2 receptor (DRD2) gene: a genetic risk factor insmoking / D.E.
Comings, L.Ferry, S.Bradshaw-Robinson, R.Burchette, C. Chiu,D.Muhleman // Pharmacogenetics. – 1996. – V.6. - №1. – P. 73–79.78.Cools, R. Dopaminergic modulation of cognitive function-implications for LDOPA treatment in Parkinson’s disease / R. Cools // Neurosci Biobehav Rev. –2006.
– V. 30. - №1. – P. 1-23.79.Cools, R. L-DOPA disrupts activity in the nucleus accumbens during reversallearning in Parkinson’s disease / R. Cools, S.J. Lewis, L. Clark, R.A. Barker,T.W. Robbins // Neuropsychopharmacology: Official Publication of theAmerican College of Neuropsychopharmacology. – 2007. – V. 32. - №1.
– P.180-189.80.Cools, R. Serotonin and dopamine: Unifying affective, activational, and decisionfunctions / R. Cools, K. Nakamura, N.D. Daw // Neuropsychopharmacology:Official Publication of the American College of Neuropsychopharmacology –2011. – V. 36. - №1. – P. 98-113.81.Cools, R. Striatal dopamine predicts outcome specific revers all earning and itssensitivity to dopaminergic drug administration / R. Cools, M.J. Frank, S.E.Gibbs, A. Miyakawa, W.
Jagust, M. D’Esposito // J Neurosci. – 2009. – V.29. №5. – P. 1538-1543.82.Cooper J.R., Bloom F.E., Roth R.H. The Biochemical Basis ofNeuropharmacology. Oxford University Press: New York. 1986.19683.Cormier, F. Genetics of impulse control disorders in Parkinson’s disease / F.Cormier, J. Mueliner, J.C. Corvol // Journal of Neural Transmission. – 2012.
–V. 120. - №4. – P. 665-671.84.Crossman, A.R. A hypothesis on the pathophysiological mechanisms thatunderlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson’sdisease: Implications for future strategies in treatment / A.R. Crossman //Movement Disorders: Official Journal of the Movement Disorder Society.
–1990. – V. 5. - №2. – P. 100-108.85.Cubells, J.F. A haplotype at the DBH locus, associated with low plasmadopamine beta-hydroxylase activity, also associates with cocaine-inducedparanoia / J.F. Cubells, H.R. Kranzler, E. McCance-Katz., G.M. Anderson, R.T.Malison, L.H. Price, J. Gelernter // Mol Psychiatry. – 2000. – V. 5. - №1. – P.56-63.86.Dalley, J.W. Nucleus accumbens D2/3 receptors predict trait impulsivity andcocaine reinforcement / J.W. Dalley, T.D. Fryer, L. Brichard, E.S. Robinson,D.E.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
